{"uri":"neural-progenitor-cells-derived-from-human-induced-ntrdem6","version_id":"3","protocol_name":"Neural progenitor cells derived from human induced pluripotent stem cells.","protocol_name_html":"Neural progenitor cells derived from human induced pluripotent stem cells.","is_prepublished":"0","can_edit":"0","parent_id":"10693","api_version":"1","is_new_mode":"0","last_modified":"1534208878","type_id":"1","link":"1 BGI-Shenzhen, Shenzhen, China","fork_id":"","public_fork_note":"","number_of_steps":"5","has_versions":"1","first_published_date":"1521199561","publish_date":"2018-08-14 01:07:58","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-39","mod_secs":"28","description":"<p>Here we present a neural differentiation protocol for generating neural progenitor cells (NPCs) from human induced pluripotent stem cells (hiPSCs). Briefly, human dermal fibroblasts were reprogrammed into hiPSCs via non-integrative reprogramming approach. Subsequently, hiPSCs were differentiated into NPCs by forming neural rosettes <em>in vitro<\/em>. Characteristic morphological changes were observed and neural markers were highly enriched in the rosettes stage.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":null,"has_guidelines":"0","materials":[],"warning":null,"version_class":"10693","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1521006228","protocol_affiliation":"BGI-Shenzhen, Shenzhen, China","affiliation":"BGI-Shenzhen, Shenzhen, China","doi":"dx.doi.org\/10.17504\/protocols.io.ntrdem6","doi_status":"2","changed_fork_steps":null,"profile_url":"QuanLei-y2037423w2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/uejje3n.jpg","full_name":"QuanLei Wang","created_by":"QuanLei Wang","private_link":"137F2B1DB546B8359CA4208F8442E8EF","original_img":"1","username":"quanlei-wang","is_retracted":"0","retraction_reason":null,"plos_id":null,"manuscript_citation":"","journal_name":null,"is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":294465,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"Induced Pluripotent Stem Cell, Differentiation, Neural Cell","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"2","badge_image":"\/img\/badges\/bronze.svg","badge_description":"Author!"},{"badge_id":"6","badge_image":"\/img\/badges\/socialbutterfly.svg","badge_description":"Social butterfly"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Zhouchun Shang,Dongsheng Chen,Quanlei Wang,Shengpeng Wang","authors_list":[{"name":"Zhouchun Shang","affiliation":"BGI-Shenzhen, Shenzhen, China","username":null,"profile_image":null},{"name":"Dongsheng Chen","affiliation":"BGI-Shenzhen, Shenzhen, China","username":null,"profile_image":null},{"name":"Quanlei Wang","affiliation":"BGI-Shenzhen, Shenzhen, China","username":null,"profile_image":null},{"name":"Shengpeng Wang","affiliation":"BGI-Shenzhen, Shenzhen, China","username":null,"profile_image":null}],"user":{"profile_image":"https:\/\/s3.amazonaws.com\/pr-journal\/uejje3n.jpg","username":"quanlei-wang","full_name":"QuanLei Wang","created_by":"QuanLei Wang"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":null,"status_id":"1","is_research":"1","status_info":"We use this protocol in our group and it is working","steps":[{"id":"614349","is_changed":"0","original_id":"614015","is_skipped":"0","is_checked":"0","guid":"FF1BDC3992734074802D6221E3262DE6","previous_guid":null,"previous_id":null,"last_modified":"1521006228","components":[{"component_id":"1071504","previous_id":0,"original_id":"1070768","guid":"7477FD1D159E43CCB59222A9BFB00B0D","previous_guid":null,"component_type_id":"6","data_id":null,"data":"Cell culture of dermal fibroblasts","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Cell culture of dermal fibroblasts"},"is_project":0},{"component_id":"1071505","previous_id":"1071504","original_id":"1070769","guid":"44AB8C2CD248463DB46986CD01A584B6","previous_guid":"7477FD1D159E43CCB59222A9BFB00B0D","component_type_id":"1","data_id":null,"data":"<p style=\"text-align: left;\">The project was approved by the Institutional Review Boards on Ethics Committee of BGI (Permit No.BGI-IRB 14057).\u00a0The human fibroblast cell line was derived from the dermal skin of a healthy female donor with written informed consent. Briefly, the skin tissue was washed with DPBS 3-5 times, sliced into approximately 1mm or smaller fragment size, enzymatically dissociated in High Dulbecco's modified Eagle medium (H-DMEM, Gibco, 11965118) with 100U\/ml collagenase type IV incubating in 37\u00b0C overnight, then 0.05% trypsin incubating for 5 min. The dissociation was terminated by adding 2 ml fibroblast cell culture medium (H-DMEM +10% FBS + 5ng\/ml bFGF+ 2mM Gln) followed by centrifugation at 300g for 5 min. Cells were resuspended with 2ml fibroblast cell culture medium and seeded in 35mm dishes and cultured at 37\u00b0C in a 5% CO<sub>2<\/sub> incubator. The fibroblast cell culture medium was changed every 2 days until reaching 80%\u201390% confluence (Fig. 1a, b) at day 8. After that, cells were passaged every 3-4 days.<\/p>\n<p><br \/><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue4je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue4je3n.jpg\" data-ofn=\"F1.jpg\" \/><\/p>\n<p style=\"text-align: left;\">\u00a0Fig.1 Bright field images of cultured human fibroblasts. Magnification = 40x, 100x respectively.<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p style=\"text-align: left;\">The project was approved by the Institutional Review Boards on Ethics Committee of BGI (Permit No.BGI-IRB 14057).\u00a0The human fibroblast cell line was derived from the dermal skin of a healthy female donor with written informed consent. Briefly, the skin tissue was washed with DPBS 3-5 times, sliced into approximately 1mm or smaller fragment size, enzymatically dissociated in High Dulbecco's modified Eagle medium (H-DMEM, Gibco, 11965118) with 100U\/ml collagenase type IV incubating in 37\u00b0C overnight, then 0.05% trypsin incubating for 5 min. The dissociation was terminated by adding 2 ml fibroblast cell culture medium (H-DMEM +10% FBS + 5ng\/ml bFGF+ 2mM Gln) followed by centrifugation at 300g for 5 min. Cells were resuspended with 2ml fibroblast cell culture medium and seeded in 35mm dishes and cultured at 37\u00b0C in a 5% CO<sub>2<\/sub> incubator. The fibroblast cell culture medium was changed every 2 days until reaching 80%\u201390% confluence (Fig. 1a, b) at day 8. After that, cells were passaged every 3-4 days.<\/p>\n<p><br \/><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue4je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue4je3n.jpg\" data-ofn=\"F1.jpg\" \/><\/p>\n<p style=\"text-align: left;\">\u00a0Fig.1 Bright field images of cultured human fibroblasts. Magnification = 40x, 100x respectively.<\/p>"},"is_project":0}]},{"id":"614350","is_changed":"0","original_id":"614016","is_skipped":"0","is_checked":"0","guid":"03D12263193144499D8B73B26DFC0BA9","previous_guid":"FF1BDC3992734074802D6221E3262DE6","previous_id":"614349","last_modified":"1521006228","components":[{"component_id":"1071506","previous_id":0,"original_id":"1070770","guid":"FC5C0C12EE5F4B28A4BF7FED16055C3D","previous_guid":null,"component_type_id":"6","data_id":null,"data":"Non-integrative  reprogramming","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Non-integrative  reprogramming"},"is_project":0},{"component_id":"1071507","previous_id":"1071506","original_id":"1070771","guid":"85A4C117E7C74CFB8B93E531B5945BD6","previous_guid":"FC5C0C12EE5F4B28A4BF7FED16055C3D","component_type_id":"1","data_id":null,"data":"<p>For reprogramming, non-integrative human iPSCs were generated following a modified Shinya Yamanaka method [1]. Briefly, 5x10<sup>5<\/sup> human fibroblast cells at passage 4 were nucleofected with the program for human dermal fibroblast NHDF (Lonza, CC-2511) with 2.4ug episomal plasmids, including pCXLE- hOCT3\/4- shp53-F (Addgene, 27077), pCXLE- hSK (Addgene, 27078), pCXLE- hUL (Addgene, 27080). Transfected cells were cultured in a six-well plate with culture medium containing H-DMEM supplemented with 10% FBS. The cells were trypsinized and 1x10<sup>5<\/sup> cells were seeded onto a 10cm<sup>2<\/sup> dish covered with feeder and cultured in medium containing H-DMEM with 10% FBS while reaching 80% confluence at day 5. After that, the medium was changed to hiPSCs medium containing DMEM\/F12 (Gibco, 11320-033), 20% KSR (Gibco,10828-028), 2mM L-glutamine (Sigma, G8540), 0.1\u03bcM NEAA (Gibco,11140-050), 0.1\u03bcM \u03b2-Mercaptoethanol (Gibco, 21985-023) and 10ng\/ml human bFGF (Invitrogen, PHG0021). The hiPSCs medium was changed every 2 days until cell colonies were observed, since then medium was changed on a daily basis. iPSCs colonies were picked mechanically under a Nikon microscope at around day 25 and maintained in hiPSCs medium until for neural differentiation at passage 15-20 (Fig. 2a, b).<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ug8je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ug8je3n.jpg\" data-ofn=\"F2.jpg\" \/>Fig.2 Bright field images of cultured human iPSCs. Magnification = 40x, 100x respectively.<\/p>\n<p>\u00a0<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>For reprogramming, non-integrative human iPSCs were generated following a modified Shinya Yamanaka method [1]. Briefly, 5x10<sup>5<\/sup> human fibroblast cells at passage 4 were nucleofected with the program for human dermal fibroblast NHDF (Lonza, CC-2511) with 2.4ug episomal plasmids, including pCXLE- hOCT3\/4- shp53-F (Addgene, 27077), pCXLE- hSK (Addgene, 27078), pCXLE- hUL (Addgene, 27080). Transfected cells were cultured in a six-well plate with culture medium containing H-DMEM supplemented with 10% FBS. The cells were trypsinized and 1x10<sup>5<\/sup> cells were seeded onto a 10cm<sup>2<\/sup> dish covered with feeder and cultured in medium containing H-DMEM with 10% FBS while reaching 80% confluence at day 5. After that, the medium was changed to hiPSCs medium containing DMEM\/F12 (Gibco, 11320-033), 20% KSR (Gibco,10828-028), 2mM L-glutamine (Sigma, G8540), 0.1\u03bcM NEAA (Gibco,11140-050), 0.1\u03bcM \u03b2-Mercaptoethanol (Gibco, 21985-023) and 10ng\/ml human bFGF (Invitrogen, PHG0021). The hiPSCs medium was changed every 2 days until cell colonies were observed, since then medium was changed on a daily basis. iPSCs colonies were picked mechanically under a Nikon microscope at around day 25 and maintained in hiPSCs medium until for neural differentiation at passage 15-20 (Fig. 2a, b).<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ug8je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ug8je3n.jpg\" data-ofn=\"F2.jpg\" \/>Fig.2 Bright field images of cultured human iPSCs. Magnification = 40x, 100x respectively.<\/p>\n<p>\u00a0<\/p>"},"is_project":0}]},{"id":"614351","is_changed":"0","original_id":"614017","is_skipped":"0","is_checked":"0","guid":"95582801DB6E4CBE8B20518FE8BFD661","previous_guid":"03D12263193144499D8B73B26DFC0BA9","previous_id":"614350","last_modified":"1521006228","components":[{"component_id":"1071508","previous_id":0,"original_id":"1070772","guid":"911039350C1247A6A442BA6203ACD88D","previous_guid":null,"component_type_id":"6","data_id":null,"data":"Neural differentiation ","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Neural differentiation "},"is_project":0},{"component_id":"1071509","previous_id":"1071508","original_id":"1070773","guid":"95F5842B8EF74C8DAAEE3FA73FCF4F23","previous_guid":"911039350C1247A6A442BA6203ACD88D","component_type_id":"1","data_id":null,"data":"<p style=\"text-align: left;\">We applied a well-adopted neural differentiation protocol [2,3]. Briefly, human iPSCs were maintained as described above. To induce neural rosettes, hiPSCs were mechanically picked and washed with DMEM\/F12 twice, and then cultured for 4 days in suspension with 5\u00b5M dorsomorphin (Sigma, P5499) and 5\u00b5M SB431542 (Sigma, S4317) in hiPSCs medium without bFGF for embryoid bodies (EBs) formation, then the EBs were washed with DMEM\/F12 twice and attached on matrigel (BD, 354277) coated dishes (BD, 354277) and cultured in DMEM\/F12 (Gibco, 11320-033) supplemented with 20 ng\/ml bFGF, 1\u00d7N2 (Gibco, 17502-048) and 2ug\/ml heparin (Sigma,1304005) for an additional 3 or 5 days to harvest rosette-early (Ros-E) and rosette-late (Ros-L) cells, respectively. To collect neural progenitor cells (NPCs), rosettes structure that appeared in the center of attached colonies at Ros-L stage (Fig. 3a,b) were carefully harvested using pulled glass pipettes and seeded on matrigel-coated dishes and cultured in DMEM\/F12 supplemented with 1\u00d7 N2, 1\u00d7 B27 (Gibco,12587-010), 20 ng\/ml bFGF, 20 ng\/ml EGF (Invitrogen, PHG0311) and 2ug\/ml heparin (Sigma,1304005) for additional 7 days, and the medium was changed every 2 days. At day 16, the NPCs reaching approximately 80% confluence were collected (Fig. 4a, b), and all the mass or adherent cell samples were treated with TrypLE\u2122 Express Enzyme (Gibco, 12604-021) for single cell dissociation and cryopreservation in gas-phase liquid nitrogen for further use.<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue6je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue6je3n.jpg\" data-ofn=\"F3.jpg\" \/><\/p>\n<p>Fig.3 Bright field images of neural rosettes at post-5 days of rosettes formation. Magnification = 100x, 200x respectively.<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/uffje3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/uffje3n.jpg\" data-ofn=\"F4-1.jpg\" \/><\/p>\n<p>Fig.4 Bright field images of representative neural progenitor cells. Magnification = 40x, 100x respectively.<\/p>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p style=\"text-align: left;\">We applied a well-adopted neural differentiation protocol [2,3]. Briefly, human iPSCs were maintained as described above. To induce neural rosettes, hiPSCs were mechanically picked and washed with DMEM\/F12 twice, and then cultured for 4 days in suspension with 5\u00b5M dorsomorphin (Sigma, P5499) and 5\u00b5M SB431542 (Sigma, S4317) in hiPSCs medium without bFGF for embryoid bodies (EBs) formation, then the EBs were washed with DMEM\/F12 twice and attached on matrigel (BD, 354277) coated dishes (BD, 354277) and cultured in DMEM\/F12 (Gibco, 11320-033) supplemented with 20 ng\/ml bFGF, 1\u00d7N2 (Gibco, 17502-048) and 2ug\/ml heparin (Sigma,1304005) for an additional 3 or 5 days to harvest rosette-early (Ros-E) and rosette-late (Ros-L) cells, respectively. To collect neural progenitor cells (NPCs), rosettes structure that appeared in the center of attached colonies at Ros-L stage (Fig. 3a,b) were carefully harvested using pulled glass pipettes and seeded on matrigel-coated dishes and cultured in DMEM\/F12 supplemented with 1\u00d7 N2, 1\u00d7 B27 (Gibco,12587-010), 20 ng\/ml bFGF, 20 ng\/ml EGF (Invitrogen, PHG0311) and 2ug\/ml heparin (Sigma,1304005) for additional 7 days, and the medium was changed every 2 days. At day 16, the NPCs reaching approximately 80% confluence were collected (Fig. 4a, b), and all the mass or adherent cell samples were treated with TrypLE\u2122 Express Enzyme (Gibco, 12604-021) for single cell dissociation and cryopreservation in gas-phase liquid nitrogen for further use.<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue6je3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ue6je3n.jpg\" data-ofn=\"F3.jpg\" \/><\/p>\n<p>Fig.3 Bright field images of neural rosettes at post-5 days of rosettes formation. Magnification = 100x, 200x respectively.<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/uffje3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/uffje3n.jpg\" data-ofn=\"F4-1.jpg\" \/><\/p>\n<p>Fig.4 Bright field images of representative neural progenitor cells. Magnification = 40x, 100x respectively.<\/p>"},"is_project":0}]},{"id":"614352","is_changed":"0","original_id":"614018","is_skipped":"0","is_checked":"0","guid":"7FCEF1BF7C724AF2ADA4466F7189C7BB","previous_guid":"95582801DB6E4CBE8B20518FE8BFD661","previous_id":"614351","last_modified":"1521006228","components":[{"component_id":"1071510","previous_id":0,"original_id":"1070774","guid":"A562993B3B2A4EA58E580652C07F6B75","previous_guid":null,"component_type_id":"1","data_id":null,"data":"<p>HiPSCs and Ros-L cells were fixed in 4% paraformaldehyde in DPBS for 20 min and permeabilized with 1% Triton X-100 for 20 min at room temperature. After 60 min blocking with 2% normal goat serum, hiPSCs were incubated with primary antibodies OCT4 (1: 200, Abcam), NANOG (1: 200, Abcam), and Ros-L cells were incubated with primary antibodies PAX6 (1: 200, Abcam), SOX2 (1:200, Abcam), NESTIN (1: 200, Abcam), SOX1 (1: 200, Abcam), Zo-1 (1:100, Abcam) and N-CAD (1: 100, Abcam) overnight at 4 \u00b0C, then stained with secondary antibodies (goat anti rabbit IgG-Cy3 diluted1: 300 and goat anti mouse IgG-Cy3 diluted 1: 300) for 60 min at room temperature. DAPI (1: 500) was used as counter-staining for nuclei. The images were captured and analyzed with the Olympus IX73 and Image J (Fig. 5).<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ufcje3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ufcje3n.jpg\" data-ofn=\"F5.jpg\" \/><\/p>\n<p>Fig. 5 Immunostaining of well-defined markers for iPSCs including OCT4 and NANOG, and for neural rosettes including PAX6, NES (NESTIN), SOX2, SOX1, ZO-1 and N-CAD (N-CADHERIN, also known as CDH2). Scale bar represents 50 \u03bcm.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>HiPSCs and Ros-L cells were fixed in 4% paraformaldehyde in DPBS for 20 min and permeabilized with 1% Triton X-100 for 20 min at room temperature. After 60 min blocking with 2% normal goat serum, hiPSCs were incubated with primary antibodies OCT4 (1: 200, Abcam), NANOG (1: 200, Abcam), and Ros-L cells were incubated with primary antibodies PAX6 (1: 200, Abcam), SOX2 (1:200, Abcam), NESTIN (1: 200, Abcam), SOX1 (1: 200, Abcam), Zo-1 (1:100, Abcam) and N-CAD (1: 100, Abcam) overnight at 4 \u00b0C, then stained with secondary antibodies (goat anti rabbit IgG-Cy3 diluted1: 300 and goat anti mouse IgG-Cy3 diluted 1: 300) for 60 min at room temperature. DAPI (1: 500) was used as counter-staining for nuclei. The images were captured and analyzed with the Olympus IX73 and Image J (Fig. 5).<\/p>\n<p><img id=\"s-mce-img\" class=\"s-mce-img\" src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ufcje3n.jpg\" data-src=\"https:\/\/s3.amazonaws.com\/pr-journal\/ufcje3n.jpg\" data-ofn=\"F5.jpg\" \/><\/p>\n<p>Fig. 5 Immunostaining of well-defined markers for iPSCs including OCT4 and NANOG, and for neural rosettes including PAX6, NES (NESTIN), SOX2, SOX1, ZO-1 and N-CAD (N-CADHERIN, also known as CDH2). Scale bar represents 50 \u03bcm.<\/p>"},"is_project":0},{"component_id":"1071511","previous_id":"1071510","original_id":"1070775","guid":"9B931A69734743548C7D41FF144BD114","previous_guid":"A562993B3B2A4EA58E580652C07F6B75","component_type_id":"6","data_id":null,"data":"Immunofluorescence staining","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Immunofluorescence staining"},"is_project":0}]},{"id":"614353","is_changed":"0","original_id":"614019","is_skipped":"0","is_checked":"0","guid":"36394321B759488382F7DBF8CAC268F4","previous_guid":"7FCEF1BF7C724AF2ADA4466F7189C7BB","previous_id":"614352","last_modified":"1521006228","components":[{"component_id":"1071512","previous_id":0,"original_id":"1070776","guid":"90720C813D624960997C27A6E8E73229","previous_guid":null,"component_type_id":"6","data_id":null,"data":"References","order_id":"0","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"References"},"is_project":0},{"component_id":"1071513","previous_id":"1071512","original_id":"1070777","guid":"FB97801BBFC54AA5BA7120F88AFE0788","previous_guid":"90720C813D624960997C27A6E8E73229","component_type_id":"1","data_id":null,"data":"<ol>\n<li>Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods. 2011;8:409\u201312.<\/li>\n<li>Zhang S-C, Wernig M, Duncan ID, Br\u00fcstle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 2001;19:1129-33.<\/li>\n<li>Kim DS, Lee DR, Kim HS, Yoo JE, Jung SJ, Lim BY, et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PLoS One. 2012;7.<\/li>\n<\/ol>","order_id":"1","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ol>\n<li>Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods. 2011;8:409\u201312.<\/li>\n<li>Zhang S-C, Wernig M, Duncan ID, Br\u00fcstle O, Thomson JA. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 2001;19:1129-33.<\/li>\n<li>Kim DS, Lee DR, Kim HS, Yoo JE, Jung SJ, Lim BY, et al. Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes. PLoS One. 2012;7.<\/li>\n<\/ol>"},"is_project":0}]}]}